Log in to your Inderes Free account to see all free content on this page.
Initiator Pharma
3.06 SEK
+3.73 %
Less than 1K followers
INIT
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Initiator Pharma
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 7.39 | 4.47 | 8.14 | 6.06 | 9.24 | 6.85 | 2.96 |
| Shares | 25.4 | 29.4 | 43.8 | 52.4 | 52.5 | 56.2 | 68.5 |
| Market cap | 187.8 | 131.4 | 356.3 | 317.3 | 484.8 | 384.7 | 202.6 |
| Enterprise value | 177.2 | 113.1 | 327.3 | - | - | - | - |
| EV/S | - | - | - | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | - | - | - | - |
| EV/EBIT | neg. | neg. | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 13.52 | 6.74 | 7.39 | 6.21 | 29.08 | 16.93 | 4.74 |
| P/S | - | - | - | - | - | - | - |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 86.6 % | 92.3 % | 65.2 % | 71.6 % | 37.5 % | 96.7 % | 89.6 % |
| Gearing ratio | - | - | 38.0 % | 37.0 % | 138.4 % | - | 7.3 % |
Login required
This content is only available for logged in users